Weight Loss Capsule Not a 'Game Changer'

Monday, 23 Jun 2014 12:32 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

A capsule that's designed to help people lose weight by temporarily expanding in their stomach in order to make them feel full just before meals is not the breakthrough some anticipated, a new study suggests.

After 12 weeks, people who took the capsule -- called Gelesis100 -- lost 6.1 percent of their weight, compared with 4.1 percent for people who were given a placebo.

That difference is "very modest" Dr. Daniel Bessesen, an endocrinologist at the University of Colorado, told The New York Times. He was not involved in the study.

"It doesn't look like a game changer," Bessesen added.

However, the findings presented Sunday at an endocrinology meeting in Chicago were hailed by Boston-based Gelesis, which developed the capsule. The company said it will launch a larger study next year in effort to win regulatory approval for the capsule.

"I'm definitely impressed, absolutely," study lead investigator Dr. Arne Astrup, head of the department of nutrition, exercise and sports at the University of Copenhagen in Denmark, told The Times.

Gelesis100 is safer than many existing weight loss drugs, which act chemically on the brain to influence appetite, Astrup said.
 

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Cancer Immune Drugs Come of Age Amid Cost Concerns

Tuesday, 30 Sep 2014 09:25 AM

A raft of newcancer drugs promise better, longer-lasting treatments with feweradverse side effects -- but their high cos . . .

Chronic Sinusitis: New Drug Shows Promise

Tuesday, 30 Sep 2014 09:10 AM

An experimental drug from Sanofi and Regeneron significantly reduced congestion in in amid-stage trial on patients with  . . .

Early Childhood Antibiotics Can Lead to Obesity Years Later: Study

Tuesday, 30 Sep 2014 09:03 AM

Children who are given broad-spectrum antibiotics before the age of 2 may face a slightly higher risk of becoming obese  . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved